COVID-19 Vaccines
Part II: Debunking COVID-19 Vaccine Myths with Facts
3 min read
By Apollo 24/7, Published on - 09 February 2021, Updated on - 18 October 2022
Share this article
1
5 likes

COVID-19 Vaccines: Myths and Facts
Myth #1: People who have recovered from COVID-19 don’t need vaccines
Myth #2: People with underlying medical conditions shouldn’t get a COVID-19 vaccine
Myth #3: Healthy people with good immune function don’t need a COVID-19 vaccine
Myth #4: People who have received the COVID-19 vaccines will test positive for the virus
Myth #5: People who have received COVID-19 vaccines can stop wearing masks
Conclusion
COVID-19 Vaccines
Leave Comment
Recommended for you

COVID-19 Vaccines
Frequently Asked Questions on COVID-19 vaccines
India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.

COVID-19 Vaccines
Debunking COVID-19 Vaccine Myths with Facts
The apprehensions and fears about COVID-19 vaccines have been fueled to a great extent by the myths and misconceptions circulating on social media.

COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories

Tips to manage COVID-19 vaccine side effects
Tap to continue exploring
Recommended for you

COVID-19 Vaccines
Frequently Asked Questions on COVID-19 vaccines
India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.

COVID-19 Vaccines
Debunking COVID-19 Vaccine Myths with Facts
The apprehensions and fears about COVID-19 vaccines have been fueled to a great extent by the myths and misconceptions circulating on social media.

COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.